Inhibition of Both Stage I and Stage II Mouse Skin Tumor Promotion by Retinoic Acid and the Dependence of Inhibition of Tumor Promotion on the Duration of Retinoic Acid Treatment

Cancer Research

Volumn 47, Issue 19, 1987, Pages 5092-5140

  Verma, Ajit K ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; MEZEREIN; PHORBOL ESTER; RETINOIC ACID;

ANIMAL EXPERIMENT; CANCER CHEMOTHERAPY; CANCER INHIBITION; HISTOLOGY; MOUSE; NONHUMAN; SKIN; SKIN CARCINOGENESIS; THERAPY; TUMOR PROMOTION; TUMOR PROMOTION INHIBITOR;

ANIMAL; FEMALE; MICE; ORNITHINE DECARBOXYLASE; PROTO-ONCOGENES; SKIN NEOPLASMS; SUPPORT, U.S. GOV'T, P.H.S.; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TRETINOIN;

EID: 84965814821     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Boutwell, R. K. The function and mechanism of promoters of carcinogenesis. CRC Crit. Rev. Toxicol. 2:419-443,1974.
2. Slaga, T. J., Fischer, S. M., Nelson, K., and Gleason, G. L. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. Proc. Natl. Acad. Sci. USA, 77:3659-3663,1980.
3. Verma, A. K., and Boutwell, R. K. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate, on mouse skin carcinogenesis. Carcinogenesis (Lond.), 1:271-276,1980.
4. Furstenberger, G., Berry, D. L., Sorg, B., and Marks, F. Skin tumor promotion by phorbol esters is a two-stage process. Proc. Natl Acad. Sci. USA, 78:7722-7726,1981.
5. Furstenberger, G., and Marks, F. Growth stimulation and tumor promotion in skin. J. Invest. Dermatol., 81:157s-161s, 1983.
6. Verma, A. K., Shapas, B. G., Rice, H. M., and Boutwell, R. K. Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion. Cancer Res., 39:419-425, 1979.
7. Verma, A. K., Duvick, L., and Ali, M. Modulation of mouse skin tumor promotion by dietary 13-cis-retinoic acid and a-difluoromethylornithine. Carcinogenesis (Lond.), 7:1019-1023,1986.
8. Verma, A. Inhibition of mouse skin tumor promotion by retinoids. In: K. N. Prasad (ed.), Advances in Vitamins, Nutrition, and Cancer. Basel: Karger, in press, 1986.
9. Slaga, T. J., Klein-Szanto, A. J. P., Fischer, S. M., Weeks, C. E., Nelson, K., and Mayor, S. Studies on mechanism of action of antitumor-promoting agents: their specificity in two-stage tumor promotion. Proc. Natl. Acad. Sci. USA, 77:2252-2254, 1980.
10. Verma, A., Conrad, E. A., and Boutwell, R. K. Differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the complete carcinogenesis process and by the initiation-promotion regimen. Cancer Res., 42:3519-3525,1982.
11. Hollander, M., and Wolfe, D. A. Nonparametric Statistical Methods, pp. 68–74. New York: John Willey Sons, Inc., 1973.
12. DiGiovanni, J., Slaga, T. J., and Boutwell, R. K. Comparison of the tumor- initiating activity of 7,12-dimethylbenz(a)anthracene and benzo(a)pyrene in female SENCAR and CD-1 mice. Carcinogenesis (Lond.), 1:381-389,1980.
13. DeLuca, H. F. Retinoic acid metabolism. Fed. Proc., 38:2519-2523,1979.
14. DeLuca, H. F. The metabolism of vitamin A and its functions. In.: E. C. Butterworth, Jr., and M. L. Hutchinson (eds.), Nutritional Factors in the Induction and Maintenance of Malignancy, pp. 149–167. New York: Academic Press, Inc., 1983.
15. Peck, G. L. Retinoids in clinical dermatology. In: R. Fleischmajer (ed.), Progress in Diseases of Skin, Vol. 1, pp. 227–269. New York: Grune and Stratton, 1981.
16. Orfanos, C. E. Oral retinoids—present status. Br. J. Dermatol., 103: 473–481, 1980.
17. Voorhees, J. J., and Orfanos, C. E. Oral retinoids. Arch. Dermatol., 117: 418–421, 1981.
18. Hill, D., and Grubbs, C. J. Retinoids as chemopreventive and anticancer agents in intact animals (review). Anticancer Res., 2:111-124,1982.
19. Yarita, T., Nettesheim, P., and Mitchell, T. J. Failure of two retinoids to inhibit tracheal carcinogenesis in hamsters. Carcinogenesis (Lond.), 1: 255–262, 1980.
20. Welsch, C. W., Goodrich-Smith, M., Brown, C. K., and Gowe, N. Enhancement by retinyl acetate of hormone-induced mammary tumorigenesis in female GR/A mice. J. Natl. Cancer Inst., 67:935-938, 1981.
21. Welsch, C. W., DeHoog, J. V., and Moon, R. C. Lack of an effect of dietary retinoids in chemical carcinogenesis of the mouse mammary gland: inverse relationship between mammary tumor cell anaplasia and retinoid efficacy. Carcinogenesis (Lond.), 5:1301-1304, 1984.
22. Gensler, H., and Bowden, G. T. Influence of 13-cis-retinoic acid on mouse skin tumor initiation and promotion. Cancer Lett., 22:71-75,1984.
23. Hennings, H., and Yuspa, S. H. Two stage tumor promotion in mouse skin: an alternative interpretation. J. Natl. Cancer Inst., 74: 735–740, 1985.
24. Gensler, H. L., Sim, D. A., and Bowden, G. T. Influence of the duration of topical 13-cir-retinoic acid treatment on inhibition of mouse skin tumor promotion. Cancer Res., 46: 2767–2770, 1986.
25. Mufsan, R. A., Fischer, S. M., Verma, A. K., Gleason, G. L., Slaga, T. J., and Boutwell, R. K. Effects of 12-O-tetradecanoylphorbol-13-acetate and mezerein on epidermal ornithine decarboxylase activity, isoproterenol-stimulated levels of cyclic adenosine 3':5’-monophosphate, and induction of mouse skin tumors in vivo. Cancer Res., 39:4791-4795, 1979.
26. Verma, A. K. Inhibition of protein kinase C-mediated mouse epidermal c-myc and ornithine decarboxylase gene transcription by retinoic acid. J. Nutr. Growth Cancer, 4:65,1987.
27. Toftgard, R., Roop, D., and Yuspa, S. H. Proto-oncogene expression during two-stage carcinogenesis in mouse skin. Carcinogenesis (Lond.), 6:655-657, 1985.
28. Bishop, J. M. The molecular genetics of cancer. Science (Wash. DC), 235: 305-311,1986.
29. Studzinski, G. P., Brelvi, Z. S., Feldman, S. C., and Watt, R. A. Participation of c-myc protein in DNA synthesis of human cells. Science (Wash. DC), 234: 467–470, 1986.
30. Griep, A. E., and DeLuca, H. F. Decreased c-myc expression is an early event in retinoic acid-induced differentiation of F9 teratocarcinoma cells. Proc. Natl. Acad. Sci. USA, 83:5539-5543,1986.
31. Hennings, H., Wenk, M. L., and Donahoe, R. Retinoic acid promotion of papilloma formation in mouse skin. Cancer Lett., 16: 1–5, 1982.
32. Fischer, S. M., Klein-Szanto, A. J. P., Adams, L. M., and Slaga, T. J. The first stage and complete promoting activity of retinoic acid but not the analog RO 10–9359. Carcinogenesis (Lond.), 6: 575-578,1985.
33. Verma, A. K., and Erickson, D. Retinoic acid (RA) and multi-stage carcinogenesis in mouse skin: inhibition of Stage I and Stage II tumor promotion and ODC-gene transcription by RA. Proc. Am. Assoc. Cancer Res., 27:147, 1986